Pathologic upstaging and survival outcomes for patients undergoing segmentectomy versus lobectomy in clinical stage T1cN0M0 non–small cell lung cancer
In patients with cT1cN0M0 NSCLC, overall survival outcomes are similar between segmentectomy recipients and lobectomy recipients, including those incidentally found to have pN1+, suggesting a potential role of lobe-preserving approaches. Additionally, completion lobectomy may not offer a survival benefit in cT1cN0M0 patients incidentally discovered to have pathologic N1 nodes.
Authors
- Chitaru Kurihara (ORCID: https://orcid.org/0000-0003-3536-4675)
- Emily Cerier (ORCID: https://orcid.org/0000-0002-0095-2592)
- Charles D. Logan (ORCID: https://orcid.org/0000-0002-2184-8954)
- Kalvin C. Lung (ORCID: https://orcid.org/0009-0001-6861-7010)
- Sandeep Bharadwaj (ORCID: https://orcid.org/0000-0003-0561-5103)
- Ankit Bharat (ORCID: https://orcid.org/0000-0002-1248-0457)
- Diego M. Avella Patino (ORCID: https://orcid.org/0000-0001-7387-8605)
- Samuel S. Kim (ORCID: https://orcid.org/0000-0001-8889-478X)
- Erik E. Rabin (ORCID: https://orcid.org/0000-0002-8967-6482)
- Ryan C Jacobs (ORCID: https://orcid.org/0009-0000-0409-6167)
- Hee Chul Yang (ORCID: https://orcid.org/0000-0001-9054-5829)
- Raheem D Bell
Institutions
- Northwestern University (US)
Publication Details
- Journal
- JTCVS Open
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1016/j.xjon.2025.01.014
- Citations
- 2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Northwestern University
- National Cancer Institute